Literature DB >> 11470588

Receptor-mediated gene transfer by phage-display vectors: applications in functional genomics and gene therapy.

D Larocca1, A Baird.   

Abstract

Recent studies have demonstrated targeted gene-delivery to mammalian cells using modified phage-display vectors. Specificity is determined by the choice of the genetically displayed targeting ligand. Without targeting, phage particles have virtually no tropism for mammalian cells. Thus, novel ligands can be selected from phage libraries by their ability to deliver a reporter gene to targeted cells. Together with advances in cDNA display technologies, these findings offer new opportunities for the use of phage-display technology in functional genomics. In addition, targeted phage particles have potential as alternative gene therapy vectors that can be further improved using directed evolution.

Entities:  

Year:  2001        PMID: 11470588     DOI: 10.1016/s1359-6446(01)01837-2

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  11 in total

1.  Open reading frame mining identifies a TLR4 binding domain in the primary sequence of ECRG4.

Authors:  Xitong Dang; Raul Coimbra; Liang Mao; Sonia Podvin; Xue Li; Hua Yu; Todd W Costantini; Xiaorong Zeng; Dana Larocca; Brian P Eliceiri; Andrew Baird
Journal:  Cell Mol Life Sci       Date:  2019-06-12       Impact factor: 9.261

2.  Pseudovirions as vehicles for the delivery of siRNA.

Authors:  Paul E Lund; Ryan C Hunt; Michael M Gottesman; Chava Kimchi-Sarfaty
Journal:  Pharm Res       Date:  2009-12-09       Impact factor: 4.200

3.  Targeting the choroid plexus-CSF-brain nexus using peptides identified by phage display.

Authors:  Andrew Baird; Brian P Eliceiri; Ana Maria Gonzalez; Conrad E Johanson; Wendy Leadbeater; Edward G Stopa
Journal:  Methods Mol Biol       Date:  2011

4.  Targeting the gut barrier: identification of a homing peptide sequence for delivery into the injured intestinal epithelial cell.

Authors:  Todd W Costantini; James G Putnam; Ritsuko Sawada; Andrew Baird; William H Loomis; Brian P Eliceiri; Vishal Bansal; Raul Coimbra
Journal:  Surgery       Date:  2009-08       Impact factor: 3.982

Review 5.  Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos.

Authors:  Mahdi Karimi; Hamed Mirshekari; Seyed Masoud Moosavi Basri; Sajad Bahrami; Mohsen Moghoofei; Michael R Hamblin
Journal:  Adv Drug Deliv Rev       Date:  2016-03-17       Impact factor: 15.470

Review 6.  Molecular Sensing with Host Systems for Hyperpolarized 129Xe.

Authors:  Jabadurai Jayapaul; Leif Schröder
Journal:  Molecules       Date:  2020-10-11       Impact factor: 4.411

Review 7.  Bacteriophages and their applications in the diagnosis and treatment of hepatitis B virus infection.

Authors:  Babak Bakhshinejad; Majid Sadeghizadeh
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

8.  Targeting choroid plexus epithelia and ventricular ependyma for drug delivery to the central nervous system.

Authors:  Ana Maria Gonzalez; Wendy E Leadbeater; Michael Burg; Karen Sims; Tetsuya Terasaki; Conrad E Johanson; Edward G Stopa; Brian P Eliceiri; Andrew Baird
Journal:  BMC Neurosci       Date:  2011-01-07       Impact factor: 3.288

9.  Metastatic prostate cancer cell-specific phage-like particles as a targeted gene-delivery system.

Authors:  Olusegun A Fagbohun; Robert A Kazmierczak; Valery A Petrenko; Abraham Eisenstark
Journal:  J Nanobiotechnology       Date:  2013-09-23       Impact factor: 10.435

10.  Killing cancer cells by targeted drug-carrying phage nanomedicines.

Authors:  Hagit Bar; Iftach Yacoby; Itai Benhar
Journal:  BMC Biotechnol       Date:  2008-04-03       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.